Orion Biotech Opportunities Corp. (NASDAQ:ORIAW – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 2,400 shares, a growth of 242.9% from the April 15th total of 700 shares. Based on an average daily trading volume, of 10,100 shares, the short-interest […]
/PRNewswire/ DelveInsight s Spinal Implants Market Insights report provides the current and forecast market, upcoming device innovation, individual leading.
/PRNewswire/ DelveInsight s Spinal Implants Market Insights report provides the current and forecast market, upcoming device innovation, individual leading.
As per DelveInsight analysis, the Spinal Implants market size is anticipated to increase owing to the rising prevalence of various spinal disorders, which include spinal stenosis, disc herniation
SPACs End Week on a High (Kind of)
The SPAC market is still stuck in a kind of stasis with most SPACs meaningfully below NAV, or for a rare few with deals fighting to stay above, but at least it didn t get worse today.
Author:
Investors saw the broader market rebound from a dismal few days with the S&P up 1.49% and the NASDAQ up 2.32% and even SPACs showed some lift. That said, the average pre-deal SPAC is still trading at $9.83 well below NAV.
Yesterday we pointed out that the pitchforks are out for Chamath and SPACs and today will have been a nice, if minor, respite for both.